ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
5
views
0
references
Top references
cited by
108
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,613
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Multidrug resistance (MDR) in cancer
Author(s):
Rajesh Krishna
,
Lawrence D Mayer
Publication date
Created:
October 2000
Publication date
(Print):
October 2000
Journal:
European Journal of Pharmaceutical Sciences
Publisher:
Elsevier BV
Read this article at
ScienceOpen
Publisher
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Cancer Metabolism
Author and article information
Journal
Title:
European Journal of Pharmaceutical Sciences
Abbreviated Title:
European Journal of Pharmaceutical Sciences
Publisher:
Elsevier BV
ISSN (Print):
09280987
Publication date Created:
October 2000
Publication date (Print):
October 2000
Volume
: 11
Issue
: 4
Pages
: 265-283
Article
DOI:
10.1016/S0928-0987(00)00114-7
SO-VID:
91d83539-f432-4d06-9272-b7086b471121
Copyright ©
© 2000
License:
http://www.elsevier.com/tdm/userlicense/1.0/
History
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
3,613
MYCOBACT-15 - Pharmacocinétique plasmatique de la bédaquiline lors du traitement des tuberculoses MDR/XDR
Authors:
P Gilles
,
E Bouvet
,
S. Perrineau
…
Medium-chain dehydrogenases/reductases (MDR). Family characterizations including genome comparisons and active site modeling.
Authors:
Erik Nordling
,
Hans Jörnvall
,
Bengt A Persson
The MDR's usability/human factors requirements
Authors:
See all similar
Cited by
97
Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer
Authors:
Gaofeng Liang
,
Yanliang Zhu
,
Doulathunnisa Ali
…
Biocompatible Polymer Nanoparticles for Drug Delivery Applications in Cancer and Neurodegenerative Disorder Therapies
Authors:
Eleonora Calzoni
,
Alessio Cesaretti
,
Alice Polchi
…
Recent Advances in Subcellular Targeted Cancer Therapy Based on Functional Materials
Authors:
Wei-Hai Chen
,
Guo-Feng Luo
,
Xian-Zheng Zhang
See all cited by